Genetic analysis of Down syndrome facilitated by mouse chromosome engineering

Li Zhang, Dawei Fu, Pavel V. Belichenko, Chunhong Liu, Alexander M. Kleschevnikov, Annie Pao, Ping Liang, Steven J. Clapcote, William C. Mobley, Y. Eugene Yu

Research output: Contribution to journalArticle

Abstract

Human trisomy 21 is the most frequent live-born human aneuploidy and causes a constellation of disease phenotypes classified as Down syndrome, which include heart defects, myeloproliferative disorder, cognitive disabilities and Alzheimer-type neurodegeneration. Because these phenotypes are associated with an extra copy of a human chromosome, the genetic analysis of Down syndrome has been a major challenge. To complement human genetic approaches, mouse models have been generated and analyzed based on evolutionary conservation between the human and mouse genomes. These efforts have been greatly facilitated by Cre/loxP-mediated mouse chromosome engineering, which may result in the establishment of minimal critical genomic regions and eventually new dosagesensitive genes associated with Down syndrome phenotypes. The success in genetic analysis of Down syndrome will further enhance our understanding of this disorder and lead to better strategies in developing effective therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)8-12
Number of pages5
JournalBioengineered Bugs
Volume3
Issue number1
DOIs
StatePublished - Jan 2012
Externally publishedYes

Fingerprint

Chromosomes
Down Syndrome
Genes
Medical Genetics
Conservation
Phenotype
Defects
Myeloproliferative Disorders
Human Chromosomes
Aneuploidy
Human Genome
Therapeutics

Keywords

  • Chromosome engineering
  • Down syndrome
  • Genetic dissection
  • Mouse models
  • Trisomy 21

ASJC Scopus subject areas

  • Bioengineering
  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

Zhang, L., Fu, D., Belichenko, P. V., Liu, C., Kleschevnikov, A. M., Pao, A., ... Yu, Y. E. (2012). Genetic analysis of Down syndrome facilitated by mouse chromosome engineering. Bioengineered Bugs, 3(1), 8-12. https://doi.org/10.4161/bbug.3.1.17696

Genetic analysis of Down syndrome facilitated by mouse chromosome engineering. / Zhang, Li; Fu, Dawei; Belichenko, Pavel V.; Liu, Chunhong; Kleschevnikov, Alexander M.; Pao, Annie; Liang, Ping; Clapcote, Steven J.; Mobley, William C.; Yu, Y. Eugene.

In: Bioengineered Bugs, Vol. 3, No. 1, 01.2012, p. 8-12.

Research output: Contribution to journalArticle

Zhang, L, Fu, D, Belichenko, PV, Liu, C, Kleschevnikov, AM, Pao, A, Liang, P, Clapcote, SJ, Mobley, WC & Yu, YE 2012, 'Genetic analysis of Down syndrome facilitated by mouse chromosome engineering', Bioengineered Bugs, vol. 3, no. 1, pp. 8-12. https://doi.org/10.4161/bbug.3.1.17696
Zhang, Li ; Fu, Dawei ; Belichenko, Pavel V. ; Liu, Chunhong ; Kleschevnikov, Alexander M. ; Pao, Annie ; Liang, Ping ; Clapcote, Steven J. ; Mobley, William C. ; Yu, Y. Eugene. / Genetic analysis of Down syndrome facilitated by mouse chromosome engineering. In: Bioengineered Bugs. 2012 ; Vol. 3, No. 1. pp. 8-12.
@article{5d1ec7b6c2394cf8a7fa51de2a700458,
title = "Genetic analysis of Down syndrome facilitated by mouse chromosome engineering",
abstract = "Human trisomy 21 is the most frequent live-born human aneuploidy and causes a constellation of disease phenotypes classified as Down syndrome, which include heart defects, myeloproliferative disorder, cognitive disabilities and Alzheimer-type neurodegeneration. Because these phenotypes are associated with an extra copy of a human chromosome, the genetic analysis of Down syndrome has been a major challenge. To complement human genetic approaches, mouse models have been generated and analyzed based on evolutionary conservation between the human and mouse genomes. These efforts have been greatly facilitated by Cre/loxP-mediated mouse chromosome engineering, which may result in the establishment of minimal critical genomic regions and eventually new dosagesensitive genes associated with Down syndrome phenotypes. The success in genetic analysis of Down syndrome will further enhance our understanding of this disorder and lead to better strategies in developing effective therapeutic interventions.",
keywords = "Chromosome engineering, Down syndrome, Genetic dissection, Mouse models, Trisomy 21",
author = "Li Zhang and Dawei Fu and Belichenko, {Pavel V.} and Chunhong Liu and Kleschevnikov, {Alexander M.} and Annie Pao and Ping Liang and Clapcote, {Steven J.} and Mobley, {William C.} and Yu, {Y. Eugene}",
year = "2012",
month = "1",
doi = "10.4161/bbug.3.1.17696",
language = "English (US)",
volume = "3",
pages = "8--12",
journal = "Bioengineered",
issn = "2165-5979",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - Genetic analysis of Down syndrome facilitated by mouse chromosome engineering

AU - Zhang, Li

AU - Fu, Dawei

AU - Belichenko, Pavel V.

AU - Liu, Chunhong

AU - Kleschevnikov, Alexander M.

AU - Pao, Annie

AU - Liang, Ping

AU - Clapcote, Steven J.

AU - Mobley, William C.

AU - Yu, Y. Eugene

PY - 2012/1

Y1 - 2012/1

N2 - Human trisomy 21 is the most frequent live-born human aneuploidy and causes a constellation of disease phenotypes classified as Down syndrome, which include heart defects, myeloproliferative disorder, cognitive disabilities and Alzheimer-type neurodegeneration. Because these phenotypes are associated with an extra copy of a human chromosome, the genetic analysis of Down syndrome has been a major challenge. To complement human genetic approaches, mouse models have been generated and analyzed based on evolutionary conservation between the human and mouse genomes. These efforts have been greatly facilitated by Cre/loxP-mediated mouse chromosome engineering, which may result in the establishment of minimal critical genomic regions and eventually new dosagesensitive genes associated with Down syndrome phenotypes. The success in genetic analysis of Down syndrome will further enhance our understanding of this disorder and lead to better strategies in developing effective therapeutic interventions.

AB - Human trisomy 21 is the most frequent live-born human aneuploidy and causes a constellation of disease phenotypes classified as Down syndrome, which include heart defects, myeloproliferative disorder, cognitive disabilities and Alzheimer-type neurodegeneration. Because these phenotypes are associated with an extra copy of a human chromosome, the genetic analysis of Down syndrome has been a major challenge. To complement human genetic approaches, mouse models have been generated and analyzed based on evolutionary conservation between the human and mouse genomes. These efforts have been greatly facilitated by Cre/loxP-mediated mouse chromosome engineering, which may result in the establishment of minimal critical genomic regions and eventually new dosagesensitive genes associated with Down syndrome phenotypes. The success in genetic analysis of Down syndrome will further enhance our understanding of this disorder and lead to better strategies in developing effective therapeutic interventions.

KW - Chromosome engineering

KW - Down syndrome

KW - Genetic dissection

KW - Mouse models

KW - Trisomy 21

UR - http://www.scopus.com/inward/record.url?scp=84863289832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863289832&partnerID=8YFLogxK

U2 - 10.4161/bbug.3.1.17696

DO - 10.4161/bbug.3.1.17696

M3 - Article

C2 - 22126738

AN - SCOPUS:84863289832

VL - 3

SP - 8

EP - 12

JO - Bioengineered

JF - Bioengineered

SN - 2165-5979

IS - 1

ER -